Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Clearside Biomedical Inc

CLSD
Current price
1.16 USD -0.01 USD (-0.85%)
Last closed 1.16 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 64 281 164 USD
Yield for 12 month +1.75 %
Week
Month
Year
CLSD
21.11.2021 - 28.11.2021

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. Clearside Biomedical, Inc. has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Address: 900 North Point Parkway, Alpharetta, GA, United States, 30005

Analytics

WallStreet Target Price

5.67 USD

P/E ratio

Dividend Yield

Current Year

+1 327 000 USD

Last Year

+29 575 000 USD

Current Quarter

+859 000 USD

Last Quarter

+1 018 000 USD

Current Year

+1 123 000 USD

Last Year

+29 575 000 USD

Current Quarter

+717 000 USD

Last Quarter

+805 000 USD

Key Figures CLSD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -29 930 000 USD
Operating Margin TTM -821.19 %
PE Ratio
Return On Assets TTM -41.62 %
PEG Ratio
Return On Equity TTM -1310.02 %
Wall Street Target Price 5.67 USD
Revenue TTM 2 211 000 USD
Book Value -0.21 USD
Revenue Per Share TTM 0.036 USD
Dividend Share
Quarterly Revenue Growth YOY 222.9 %
Dividend Yield
Gross Profit TTM 1 123 000 USD
Earnings Share -0.61 USD
Diluted Eps TTM -0.61 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CLSD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CLSD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CLSD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 16.0015
Price Sales TTM 29.0733
Enterprise Value EBITDA -1.2581
Price Book MRQ 3.927

Financials CLSD

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CLSD

For 52 weeks

0.65 USD 1.85 USD
50 Day MA 0.89 USD
Shares Short Prior Month 290 630
200 Day MA 1.05 USD
Short Ratio 1.54
Shares Short 292 878
Short Percent 0.5 %